| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Relay Therapeutics, Inc.'s insiders have reduced their positions by a net 6,210,786 shares worth roughly $120.4M. In the past 30 days, 0 insiders bought and 2 sold.
All 2 insiders who sold still hold shares after their sales. RLAY sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 21.90M | $424.96M | - | |
| CEO | 471.3K | $8.53M | -48,199 | |
| Pres | 399.1K | $7.57M | - | |
| Other | 223.7K | $4.48M | - | |
| CFO | 105.1K | $2.02M | -17,717 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 7, 2026 | Patel Sanjiv73 | President and CEO | Sell | 48,199 | $18.10 | $872,401.90 | -9.3% | - | - | |
| Oct 6, 2026 | Catinazzo Thomas69 | Chief Financial Officer | Sell | 17,717 | $18.59 | $329,321.94 | -14.4% | - | - | |
| Sep 8, 2026 | Bergstrom Donald A74 | President, R&D | Sell | 8,530 | $18.97 | $161,814.10 | -2.1% | - | - | |
| Sep 8, 2026 | Catinazzo Thomas69 | Chief Financial Officer | Sell | 17,717 | $18.94 | $335,559.98 | -12.6% | - | - | |
| Sep 8, 2026 | Patel Sanjiv73 | President and CEO | Sell | 48,199 | $18.94 | $912,889.06 | -8.5% | - | - | |
| Aug 26, 2026 | Rahmer Peter61 | See Remarks | Sell | 4,508 | $20.03 | $90,295.24 | -2.0% | - | - | |
| Aug 25, 2026 | Svf Pauling (cayman) Ltd | 10% Owner | Sell | 6,000,000 | $19.40 | $116,400,000.00 | -21.5% | - | - | |
| Aug 17, 2026 | Patel Sanjiv73 | President and CEO | Sell | 48,199 | $20.33 | $979,885.67 | -7.8% | - | - | |
| Aug 14, 2026 | Catinazzo Thomas69 | Chief Financial Officer | Sell | 17,717 | $19.74 | $349,733.58 | -11.2% | - | - | |
| Jul 28, 2026 | Rahmer Peter61 | See Remarks | Sell | 748 | $18.61 | $13,920.28 | -0.3% | -0.6% | - |